Login / Signup

Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.

Elena CantoneLuca D'AscanioPietro De LucaDalila RoccamatisiIgnazio La La MantiaMichael J BrennerArianna Di Stadio
Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)
umPEALUT and OT, with or without ALA, was associated with improvement in TDI scores and parosmia, whereas OT alone or OT with ALA were associated with little benefit.
Keyphrases
  • coronavirus disease
  • sars cov
  • small molecule
  • clinical trial
  • double blind
  • respiratory syndrome coronavirus